152 related articles for article (PubMed ID: 30873676)
1. Cytokines and Cortisol - predictors of treatment response to corticosteroids in community-acquired pneumonia?
Urwyler SA; Blum CA; Coslovsky M; Mueller B; Schuetz P; Christ-Crain M
J Intern Med; 2019 Jul; 286(1):75-87. PubMed ID: 30873676
[TBL] [Abstract][Full Text] [Related]
2. Cosyntropin testing does not predict response to glucocorticoids in community-acquired pneumonia in a randomized controlled trial.
Blum CA; Schuetz P; Nigro N; Winzeler B; Arici B; Refardt J; Urwyler SA; Rodondi N; Blum MR; Briel M; Mueller B; Christ-Crain M
Clin Endocrinol (Oxf); 2019 Sep; 91(3):374-382. PubMed ID: 30485501
[TBL] [Abstract][Full Text] [Related]
3. Benefit of adjunct corticosteroids for community-acquired pneumonia in diabetic patients.
Popovic M; Blum CA; Nigro N; Mueller B; Schuetz P; Christ-Crain M
Diabetologia; 2016 Dec; 59(12):2552-2560. PubMed ID: 27614658
[TBL] [Abstract][Full Text] [Related]
4. Biomarkers define the clinical response to dexamethasone in community-acquired pneumonia.
Remmelts HH; Meijvis SC; Heijligenberg R; Rijkers GT; Oosterheert JJ; Bos WJ; Endeman H; Grutters JC; Hoepelman AI; Biesma DH
J Infect; 2012 Jul; 65(1):25-31. PubMed ID: 22410382
[TBL] [Abstract][Full Text] [Related]
5. Time-dependent association of glucocorticoids with adverse outcome in community-acquired pneumonia: a 6-year prospective cohort study.
Nickler M; Ottiger M; Steuer C; Kutz A; Christ-Crain M; Zimmerli W; Thomann R; Hoess C; Henzen C; Bernasconi L; Huber A; Mueller B; Schuetz P;
Crit Care; 2017 Mar; 21(1):72. PubMed ID: 28335807
[TBL] [Abstract][Full Text] [Related]
6. The effect of simvastatin on inflammatory cytokines in community-acquired pneumonia: a randomised, double-blind, placebo-controlled trial.
Viasus D; Garcia-Vidal C; Simonetti AF; Dorca J; Llopis F; Mestre M; Morandeira-Rego F; Carratalà J
BMJ Open; 2015 Jan; 5(1):e006251. PubMed ID: 25564143
[TBL] [Abstract][Full Text] [Related]
7. Corticosteroid treatment of severe community-acquired pneumonia.
Gorman SK; Slavik RS; Marin J
Ann Pharmacother; 2007 Jul; 41(7):1233-7. PubMed ID: 17519300
[TBL] [Abstract][Full Text] [Related]
8. Changes in serum cortisol levels during community-acquired pneumonia: the influence of dexamethasone.
Remmelts HH; Meijvis SC; Kovaleva A; Biesma DH; Rijkers GT; Heijligenberg R
Respir Med; 2012 Jun; 106(6):905-8. PubMed ID: 22402329
[TBL] [Abstract][Full Text] [Related]
9. Adjunct prednisone in community-acquired pneumonia: 180-day outcome of a multicentre, double-blind, randomized, placebo-controlled trial.
Blum CA; Roethlisberger EA; Cesana-Nigro N; Winzeler B; Rodondi N; Blum MR; Briel M; Mueller B; Christ-Crain M; Schuetz P
BMC Pulm Med; 2023 Dec; 23(1):500. PubMed ID: 38082273
[TBL] [Abstract][Full Text] [Related]
10. [The indications for glucocorticoids in treating community-acquired pneumonia in adults: a meta-analysis].
Tian XL; Jiang M; Sun XF; Zhan YZ; Wang SB; Kang SS
Zhonghua Jie He He Hu Xi Za Zhi; 2016 Apr; 39(4):280-5. PubMed ID: 27117073
[TBL] [Abstract][Full Text] [Related]
11. Corticosteroid treatment for community-acquired pneumonia--the STEP trial: study protocol for a randomized controlled trial.
Blum CA; Nigro N; Winzeler B; Suter-Widmer I; Schuetz P; Briel M; Bingisser R; Zimmerli W; Ullmer E; Elsaesser H; Tarr P; Wirz S; Thomann R; Hofmann E; Rodondi N; Duplain H; Burki D; Mueller B; Christ-Crain M
Trials; 2014 Jun; 15():257. PubMed ID: 24974155
[TBL] [Abstract][Full Text] [Related]
12. Sphingosine-1-phosphate as an indicator for deciding the use of adjuvant corticosteroids therapy in community-acquired pneumonia (sphingosine-1-phosphate and pneumonia trial): Study protocol for a randomized, placebo-controlled trial.
Hsu SC; Huang WC; Liu CT; Hsu YP; Chang JH; Huang SK; Hsu CW
Medicine (Baltimore); 2019 Sep; 98(38):e17278. PubMed ID: 31568009
[TBL] [Abstract][Full Text] [Related]
13. Adjunct prednisone therapy for patients with community-acquired pneumonia: a multicentre, double-blind, randomised, placebo-controlled trial.
Blum CA; Nigro N; Briel M; Schuetz P; Ullmer E; Suter-Widmer I; Winzeler B; Bingisser R; Elsaesser H; Drozdov D; Arici B; Urwyler SA; Refardt J; Tarr P; Wirz S; Thomann R; Baumgartner C; Duplain H; Burki D; Zimmerli W; Rodondi N; Mueller B; Christ-Crain M
Lancet; 2015 Apr; 385(9977):1511-8. PubMed ID: 25608756
[TBL] [Abstract][Full Text] [Related]
14. Effect of corticosteroids on treatment failure among hospitalized patients with severe community-acquired pneumonia and high inflammatory response: a randomized clinical trial.
Torres A; Sibila O; Ferrer M; Polverino E; Menendez R; Mensa J; Gabarrús A; Sellarés J; Restrepo MI; Anzueto A; Niederman MS; Agustí C
JAMA; 2015 Feb; 313(7):677-86. PubMed ID: 25688779
[TBL] [Abstract][Full Text] [Related]
15. Inhaled corticosteroids and systemic inflammatory response in community-acquired pneumonia: a prospective clinical study.
Ferrer M; Torres A; Martínez R; Ramírez P; Polverino E; Montull B; Sialer S; Niederman MS; Agusti A; Menéndez R
Respirology; 2014 Aug; 19(6):929-35. PubMed ID: 24909304
[TBL] [Abstract][Full Text] [Related]
16. Influence of steroids on procalcitonin and C-reactive protein in patients with COPD and community-acquired pneumonia.
Perren A; Cerutti B; Lepori M; Senn V; Capelli B; Duchini F; Domenighetti G
Infection; 2008 Mar; 36(2):163-6. PubMed ID: 18330505
[TBL] [Abstract][Full Text] [Related]
17. Adrenal response in severe community-acquired pneumonia: impact on outcomes and disease severity.
Salluh JIF; Bozza FA; Soares M; Verdeal JCR; Castro-Faria-Neto HC; Lapa E Silva JR; Bozza PT
Chest; 2008 Nov; 134(5):947-954. PubMed ID: 18753464
[TBL] [Abstract][Full Text] [Related]
18. Free and total cortisol levels as predictors of severity and outcome in community-acquired pneumonia.
Christ-Crain M; Stolz D; Jutla S; Couppis O; Müller C; Bingisser R; Schuetz P; Tamm M; Edwards R; Müller B; Grossman AB
Am J Respir Crit Care Med; 2007 Nov; 176(9):913-20. PubMed ID: 17702966
[TBL] [Abstract][Full Text] [Related]
19. Cortisol total/CRP ratio for the prediction of hospital-acquired pneumonia and initiation of corticosteroid therapy in traumatic brain-injured patients.
Bouras M; Roquilly A; Mahé PJ; Cinotti R; Vourc'h M; Perrot B; Bach-Ngohou K; Masson D; Asehnoune K
Crit Care; 2019 Dec; 23(1):394. PubMed ID: 31805967
[TBL] [Abstract][Full Text] [Related]
20. Dynamics of cytokines, immune cell counts and disease severity in patients with community-acquired pneumonia - Unravelling potential causal relationships.
Rosolowski M; Oberle V; Ahnert P; Creutz P; Witzenrath M; Kiehntopf M; Loeffler M; Suttorp N; Scholz M
Cytokine; 2020 Dec; 136():155263. PubMed ID: 32896803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
